Contributor Page
Email  |  Website  |  Articles
Contact Details
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
MA 02111
United States
By Aaron L. Josephson
Artificial intelligence—AI—is the future of everything. But when patient health is on the line, can we trust algorithms to make decisions instead of patients or their health care providers?
By Andrew DeVoogd, Christopher Duerden
A recent opinion from the Northern District of Texas is a reminder to all patent practitioners to heed pleading standards when drafting a complaint for patent infringement.
By Aarti Shah, Andrew DeVoogd, Daniel Weinger, Christopher Duerden
In an Initial Determination finding that Fujifilm violated Section 337 by infringing two patents held by Sony, ALJ Cheney found another patent invalid after ruling that inter partes review ("IPR")
By Joanne Hawana
In the first new guidance document from FDA in several years specific to the subject of direct-to-consumer promotion of prescription drugs and biological products, the Agency is recommending that companies take additional steps ...
By Lauren Moldawer
The Trump Administration is moving full speed ahead with its proposals under the Blueprint to Lower Drug Prices (the "Blueprint").
By Gilbert Samberg
The U.S. Supreme Court has pointed out consistently in recent years that the relatively new construct of "class arbitration" is very different from your uncle's classic bilateral arbitration.
By Matt Mora, Jordan Cohen
The Department of Health and Human Services OIG has issued Advisory Opinion No. 18-10 in response to a proposal by a surgical device and wound care product manufacturer to offer its hospital customers...
By Rodney Whitlock, Alexander Hecht, Katie Weider, Eli Greenspan
Last week concluded the Senate's time in Washington prior to the lame duck session.
By Ellen Janos
The Journal of the American Medical Association in its September 18, 2018 issue included four articles on deep learning and Artificial Intelligence (AI).
By Brad Scheller, Daniel Weinger, Courtney Herndon
Today the Patent Trial and Appeal Board announced a final rule changing the claim construction standard for interpreting claims in IPR, post-grant review ("PGR"), and covered business method patent ("CBM") proceedings.
By Christina Sperry
As in any area of technology, it is important to consider patent protection early in the development of an AI-related invention. However, AI and other digital health inventions raise a number...
By Peter Saparoff, Joel Rothman, Kevin Mortimer, Ellen Shapiro, Alain P. Mathieu
In a recent ruling in In re: BP p.l.c. Securities Litigation the United States District Court for the Southern District of Texas dismissed claims asserted by opt-out plaintiffs as time barred by the Exchange Act's statute ...
By Kate Stewart
Drug and device manufacturers will need to update their reporting systems and provide new training to their sales staff in the coming years based on changes to the Physician Payment Sunshine Act
By Rodney Whitlock, Alexander Hecht, Katie Weider, Eli Greenspan
While the House is out on recess, the Senate continues to be in session.
By Kevin Ainsworth
In an unusual decision in an unusual case—a dispute between sovereigns—a U.S. appellate court recently vacated a domestic arbitration award on grounds other than those provided in Section 10...
Contributor's Topics